Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'GP160' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 273 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Sasaki, M; Miyazaki, K; Koga, Y; Kimura, G; Nomoto, K; Yoshida, H
      Calcineurin-dependent mitochondrial disturbances in calcium-induced apoptosis of human immunodeficiency virus gp160-expressing CD4(+) cells

      JOURNAL OF VIROLOGY
    2. Imami, N; Hardy, G; Gotch, F
      Development of immunotherapeutic strategies for HIV-1

      EXPERT OPINION ON BIOLOGICAL THERAPY
    3. Bahbouhi, B; Bendjennat, M; Chiva, C; Kogan, M; Albericio, F; Giralt, E; Seidah, NG; Bahraoui, E
      Inhibition of HIV-2(ROD) replication in a lymphoblastoid cell line by the alpha 1-antitrypsin Portland variant (alpha 1-PDX) and the decRVKRcmk peptide: comparison with HIV-1(LAI)

      MICROBES AND INFECTION
    4. Derby, MA; Wang, J; Margulies, DT; Berzofsky, JA
      Two intermediate-avidity cytotoxic T lymphocyte clones with a disparity between functional avidity and MHC tetramer staining

      INTERNATIONAL IMMUNOLOGY
    5. Kundu-Raychaudhuri, S; Sevin, A; Kilgo, P; Nokta, M; Pollard, RB; Merigan, TC
      Effect of therapeutic immunization with HIV type 1 recombinant glycoprotein 160 ImmunoAG vaccine in HIV-infected individuals with CD4(+) T cell counts of <= 500 and 200-400/mm(3) (AIDS Clinical Trials Group study 246/946)

      AIDS RESEARCH AND HUMAN RETROVIRUSES
    6. Gorse, GJ; Patel, GB; Belshe, RB
      HIV type 1 vaccine-induced T cell memory and cytotoxic T lymphocyte responses in HIV type 1-uninfected volunteers

      AIDS RESEARCH AND HUMAN RETROVIRUSES
    7. Kim, JH; Mascola, JR; Ratto-Kim, S; VanCott, TC; Loomis-Price, L; Cox, JH; Michael, NL; Jagodzinski, L; Hawkes, C; Mayers, D; Gilliam, BL; Birx, DC; Robb, ML
      Selective increases in HIV-specific neutralizing antibody and partial reconstitution of cellular immune responses during prolonged, successful drug therapy of HIV infection

      AIDS RESEARCH AND HUMAN RETROVIRUSES
    8. Bahbouhi, B; Seidah, NG; Bahraoui, E
      Replication of HIV-1 viruses in the presence of the Portland alpha 1-antitrypsin variant (alpha 1-PDX) inhibitor

      BIOCHEMICAL JOURNAL
    9. Toledo, H; Baly, A; Castro, O; Resik, S; Laferte, J; Rolo, F; Navea, L; Lobaina, L; Cruz, O; Miguez, J; Serrano, T; Sierra, B; Perez, L; Ricardo, ME; Dubed, M; Lubian, AL; Blanco, M; Millan, JC; Ortega, A; Iglesias, E; Penton, E; Martin, Z; Perez, J; Diaz, M; Duarte, CA
      A phase I clinical trial of a mufti-epitope polypeptide TAB9 combined withMontanide ISA 720 adjuvant in non-HIV-1 infected human volunteers

      VACCINE
    10. Lambert, JS; Keefer, M; Mulligan, MJ; Schwartz, D; Mestecky, J; Weinhold, K; Smith, C; Hsieh, R; Moldoveanu, Z; Fast, P; Forrest, B; Koff, W
      A Phase I safety and immunogenicity trial of UBI (R) microparticulate monovalent HIV-1 MN oral peptide immunogen with parenteral boost in HIV-1 seronegative human subjects

      VACCINE
    11. Gorse, GJ; Patel, GB; Mandava, MD; Arbuckle, JA; Doyle, TM; Belshe, RB
      Cytokine responses to human immunodeficiency virus type I (HIV-1) induced by immunization with live recombinant canarypox virus vaccine expressing HIV-1 genes boosted by HIV-1(SF-2) recombinant GP120

      VACCINE
    12. Fournillier, A; Wychowski, C; Boucreux, D; Baumert, TF; Meunier, JC; Jacobs, D; Muguet, S; Depla, E; Inchauspe, G
      Induction of hepatitis C virus E1 envelope protein-specific immune response can be enhanced by mutation of N-glycosylation sites

      JOURNAL OF VIROLOGY
    13. Norris, PJ; Sumaroka, M; Brander, C; Moffett, HF; Boswell, SL; Nguyen, T; Sykulev, Y; Walker, BD; Rosenberg, ES
      Multiple effector functions mediated by human immunodeficiency virus-specific CD4(+) T-cell clones

      JOURNAL OF VIROLOGY
    14. Crotty, S; Miller, CJ; Lohman, BL; Neagu, MR; Compton, L; Lu, D; Lu, FXS; Fritts, L; Lifson, JD; Andino, R
      Protection against simian immunodeficiency virus vaginal challenge by using Sabin poliovirus vectors

      JOURNAL OF VIROLOGY
    15. Barsov, EV; Payne, WS; Hughes, SH
      Adaptation of chimeric retroviruses in vitro and in vivo: Isolation of avian retroviral vectors with extended host range

      JOURNAL OF VIROLOGY
    16. Michaud, J; Fajardo, R; Charron, G; Sauvageau, A; Berrada, F; Ramla, D; Dilhuydy, H; Robitaille, Y; Kessous-Elbaz, A
      Neuropathology of NFHgp160 transgenic mice expressing HIV-1 env protein inneurons

      JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
    17. Worku, S; Gorse, GJ; Belshe, RB; Hoft, DF
      Canarypox vaccines induce antigen-specific human gamma delta T cells capable of interferon-gamma production

      JOURNAL OF INFECTIOUS DISEASES
    18. Belshe, RB; Stevens, C; Gorse, GJ; Buchbinder, S; Weinhold, K; Sheppard, H; Stablein, D; Self, S; McNamara, J; Frey, S; Flores, J; Excler, JL; Klein, M; El Habib, R; Duliege, AM; Harro, C; Corey, L; Keefer, M; Mulligan, M; Wright, P; Celum, C; Judson, F; Mayer, K; McKirnan, D; Marmor, M; Woody, G
      Safety and immunogenicity of a canarypox-vectored human immunodeficiency virus type 1 vaccine with or without gp120: A phase 2 study in higher- and lower-risk volunteers

      JOURNAL OF INFECTIOUS DISEASES
    19. Corey, L
      Cellular and humoral immune responses to a canarypox vaccine containing human immunodeficiency virus type 1 Env, Gag, and Pro in combination with RGP120

      JOURNAL OF INFECTIOUS DISEASES
    20. Chung, DH; Belyakov, IM; Derby, MA; Wang, J; Boyd, LF; Berzofsky, JA; Margulies, DH
      Competitive inhibition in vivo and skewing of the T cell repertoire of antigen-specific CTL priming by an anti-peptide-MHC monoclonal antibody

      JOURNAL OF IMMUNOLOGY
    21. Bendjennat, M; Bahbouhi, B; Bahraoui, E
      Purification and characterization of a Ca2+-independent endoprotease activity from peripheral blood lymphocytes: Involvement in HIV-1 gp160 maturation

      BIOCHEMISTRY
    22. Lu, FX
      Predominate HIV1-specific IgG activity in various mucosal compartments of HIV1-infected individuals

      CLINICAL IMMUNOLOGY
    23. Moss, RB; Jensen, FC; Carlo, DJ
      Insights into HIV-specific immune function: Implications for therapy and prevention in the new millennium

      CLINICAL IMMUNOLOGY
    24. Johnston, MI
      The role of nonhuman primate models in AIDS vaccine development

      MOLECULAR MEDICINE TODAY
    25. Liu, YL; Tang, XP; McArthur, JC; Scott, J; Gartner, S
      Analysis of human immunodeficiency virus type 1 gp160 sequences from a patient with HIV dementia: evidence for monocyte trafficking into brain

      JOURNAL OF NEUROVIROLOGY
    26. DeMaria, A; Kunches, L; Mayer, K; Cohen, C; Epstein, P; Werner, B; Day, J; DeCristofaro, J; Landers, S; Tang, Y; Coady, W
      Immune responses to a recombinant human immunodeficiency virus type 1 (HIV-1) gp160 vaccine among adults with advanced HIV infection

      JOURNAL OF HUMAN VIROLOGY
    27. Churdboonchart, V; Sakondhavat, C; Kulpradist, S; Isarangkura, B; Ayudthya, BIN; Chandeying, V; Rugpao, S; Boonshuyar, C; Sukeepaisarncharoen, W; Sirawaraporn, W; Carlo, DJ; Moss, R
      A double-blind, adjuvant-controlled trial of human immunodeficiency virus type 1 (HIV-1) immunogen (Remune) monotherapy in asymptomatic, HIV-1-infected Thai subjects with CD4-Cell counts of > 300

      CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY
    28. Yana, I; Weiss, SJ
      Regulation of membrane type-1 matrix metalloproteinase activation by proprotein convertases

      MOLECULAR BIOLOGY OF THE CELL
    29. Dickey, C; Ziegner, U; Agadjanyan, MG; Srikantan, V; Refaeli, Y; Prabhu, A; Sato, A; Wiliiams, WV; Weiner, DB; Ugen, KE
      Murine monoclonal antibodies biologically active against the amino region of HIV-1 gp120: Isolation and characterization

      DNA AND CELL BIOLOGY
    30. Peters, BS
      HIV immunotherapeutic vaccines

      ANTIVIRAL CHEMISTRY & CHEMOTHERAPY
    31. Dolin, R
      HIV vaccines for prevention of infection and disease in humans

      INFECTIOUS DISEASE CLINICS OF NORTH AMERICA
    32. Lu, FX
      New method for quantifying anti-HIV1-gp160 antibodies in saliva, cervicovaginal secretions, and serum of infected women

      JOURNAL OF CLINICAL LABORATORY ANALYSIS
    33. Collman, RG; Yi, YJ; Liu, QH; Freedman, BD
      Chemokine signaling and HIV-1 fusion mediated by macrophage CXCR4: implications for target cell tropism

      JOURNAL OF LEUKOCYTE BIOLOGY
    34. Imai, M; Okada, N; Okada, H
      Inhibition of HIV-1 infection by an intramolecular antisense peptide to T20 in gp160

      MICROBIOLOGY AND IMMUNOLOGY
    35. Tran, NT; Taverna, M; Merry, AH; Chevalier, M; Morgant, G; Valentin, C; Ferrier, D
      A sensitive mapping strategy for monitoring the reproducibility of glycan processing in an HIV vaccine, RGP-160, expressed in a mammalian cell line

      GLYCOCONJUGATE JOURNAL
    36. Farhadi, HF; Mowla, SJ; Petrecca, K; Morris, SJ; Seidah, NG; Murphy, RA
      Neurotrophin-3 sorts to the constitutive secretory pathway of hippocampal neurons and is diverted to the regulated secretory pathway by coexpression with brain-derived neurotrophic factor

      JOURNAL OF NEUROSCIENCE
    37. Bogers, WMJM; Cheng-Mayer, C; Montelaro, RC
      Developments in preclinical AIDS vaccine efficacy models

      AIDS
    38. Bahbouhi, B; Bendjennat, M; Guetard, D; Seidah, NG; Bahraoui, E
      Effect of alpha-1 antitrypsin Portland variant (alpha 1-PDX) on HIV-1 replication

      BIOCHEMICAL JOURNAL
    39. Lissitzky, JC; Luis, J; Munzer, JS; Benjannet, S; Parat, F; Chretien, M; Marvaldi, J; Seidah, NG
      Endoproteolytic processing of integrin pro-alpha subunits involves the redundant function of furin and proprotein convertase (PC) 5A, but not paired basic amino acid converting enzyme (PACE) 4, PC5B or PC7

      BIOCHEMICAL JOURNAL
    40. Eick, A; Larned, J; Jason, J
      Effects of HIV-1 peptides on T-cell receptor variable beta chain families

      HUMAN IMMUNOLOGY
    41. McClure, P; Curran, R; Boneham, S; Ball, JK
      A polymerase chain reaction method for the amplification of full-length envelope genes of HIV-1 from DNA samples containing single molecules of HIV-1provirus

      JOURNAL OF VIROLOGICAL METHODS
    42. Zhu, YD; Koo, K; Bradshaw, JD; Sutton, WF; Kuller, L; Bucala, R; Anderson, D; Mossman, SP; Villinger, F; Haigwood, NL
      Macaque blood-derived antigen-presenting cells elicit SIV-specific immune responses

      JOURNAL OF MEDICAL PRIMATOLOGY
    43. Heeney, JL; Koopman, G; Rosenwirth, B; Bogers, W; van Dijk, J; Nieuwenhuis, I; Niphuis, H; ten Haaft, P; Hanke, T; Rhodes, G; Berglund, P; Burny, A; Bex, F; Sutter, G; Liljestrom, P
      A vaccine strategy utilizing a combination of three different chimeric vectors which share specific vaccine antigens

      JOURNAL OF MEDICAL PRIMATOLOGY
    44. Takada, A; Watanabe, S; Ito, H; Okazaki, K; Kida, H; Kawaoka, Y
      Downregulation of beta 1 integrins by Ebola virus glycoprotein: Implication for virus entry

      VIROLOGY
    45. Alian, A; Sela-Donenfeld, D; Panet, A; Eldor, A
      Avian hemangioma retrovirus induces cell proliferation via the envelope (env) gene

      VIROLOGY
    46. Jolly, PE; Weiss, HL
      Neutralization and enhancement of HIV-1 infection by sera from HIV-1 infected individuals who progress to disease at different rates

      VIROLOGY
    47. Schnell, MJ; Foley, HD; Siler, CA; McGettigan, JP; Dietzschold, B; Pomerantz, RJ
      Recombinant rabies virus as potential live-viral Vaccines for HIV-1

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    48. Lu, YC; Friedman, R; Kushner, N; Doling, A; Thomas, L; Touzjian, N; Starnbach, M; Lieberman, J
      Genetically modified anthrax lethal toxin safely delivers whole HIV protein antigens into the cytosol to induce T cell immunity

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    49. Means, RE; Desrosiers, RC
      Resistance of native, oligomeric envelope on simian immunodeficiency virusto digestion by glycosidases

      JOURNAL OF VIROLOGY
    50. Bultmann, A; Eberle, J; Haas, J
      Ubiquitination of the human immunodeficiency virus type 1 Env glycoprotein

      JOURNAL OF VIROLOGY
    51. Leandersson, AC; Gilljam, G; Fredriksson, M; Hinkula, J; Alaeus, A; Lidman, K; Albert, J; Bratt, G; Sandstrom, E; Wahren, B
      Cross-reactive T-helper responses in patients infected with different subtypes of human immunodeficiency virus type 1

      JOURNAL OF VIROLOGY
    52. Chang, SY; Vithayasai, V; Vithayasai, P; Essex, M; Lee, TH
      Human immunodeficiency virus type 1 subtype E envelope recombinant peptides containing naturally immunogenic epitopes

      JOURNAL OF INFECTIOUS DISEASES
    53. Binley, JM; Schiller, DS; Ortiz, GM; Hurley, A; Nixon, DF; Markowitz, MM; Moore, JP
      The relationship between T cell proliferative responses and plasma viremiaduring treatment of human immunodeficiency virus type 1 infection with combination antiretroviral therapy

      JOURNAL OF INFECTIOUS DISEASES
    54. Zent, R; Fenczik, CA; Calderwood, DA; Liu, SC; Dellos, M; Ginsberg, MH
      Class- and splice variant-specific association of CD98 with integrin beta cytoplasmic domains

      JOURNAL OF BIOLOGICAL CHEMISTRY
    55. Katzenstein, DA; Kundu, S; Spritzler, J; Smoller, BR; Haszlett, P; Valentine, F; Merigan, TC
      Delayed-type hypersensitivity to recombinant HIV envelope glycoprotein (rgp160) after immunization with homologous antigen

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    56. Deml, L; Schirmbeck, R; Reimann, J; Wolf, H; Wagner, R
      Immunostimulatory CpG motifs trigger a T helper-1 immune response to humanimmunodeficiency virus type-1 (HIV-1) gp160 envelope proteins

      CLINICAL CHEMISTRY AND LABORATORY MEDICINE
    57. Bratt, G; Eriksson, LE; Sandstrom, E; Gilljam, G; Hinkula, J; Albert, J; Redfield, R; Wahren, B
      Long-term immunotherapy in HIV infection, combined with short-term antiretroviral treatment

      INTERNATIONAL JOURNAL OF STD & AIDS
    58. Frey, SE
      HIV vaccines

      INFECTIOUS DISEASE CLINICS OF NORTH AMERICA
    59. Benson, EM; Clarkson, J; Law, M; Marshall, P; Kelleher, AD; Smith, DE; Patou, G; Stewart, GJ; Cooper, DA; Ffrench, RA
      Therapeutic vaccination with p24-VLP and zidovudine augments HIV-specific cytotoxic T lymphocyte activity in asymptomatic HIV-infected individuals

      AIDS RESEARCH AND HUMAN RETROVIRUSES
    60. Gorse, GJ; Corey, L; Patel, GB; Mandava, M; Hsieh, RH; Matthews, TJ; Walker, MC; McElrath, MJ; Berman, PW; Eibl, MM; Belshe, RB
      HIV-1(MN) recombinant glycoprotein 160 vaccine-induced cellular and humoral immunity boosted by HIV-1(MN) recombinant glycoprotein 120 vaccine

      AIDS RESEARCH AND HUMAN RETROVIRUSES
    61. Carruth, LM; Greten, TF; Murray, CE; Castro, MG; Crone, SN; Pavlat, W; Schneck, JP; Siliciano, RF
      An algorithm for evaluating human cytotoxic T lymphocyte responses to candidate AIDS vaccines

      AIDS RESEARCH AND HUMAN RETROVIRUSES
    62. Arp, J; Rovinski, B; Sambhara, S; Tartaglia, J; Dekaban, G
      Human immunodeficiency virus type 1 envelope-specific cytotoxic T lymphocytes response dynamics after prime-boost vaccine regimens with human immunodeficiency virus type 1 canarypox and pseudovirions

      VIRAL IMMUNOLOGY
    63. Chiba, M; Takahashi, H; Kato, K; Nakagawa, Y; Fukushima, T; Iinuma, H; Nerome, K
      Recombinant vaccinia viruses expressing an immunodominant epitope of HIV-1envelope protein within an influenza hemagglutinin cassette predominantly prime epitope-specific CD8(+) CTL

      ARCHIVES OF VIROLOGY
    64. Janssens, W; Heyndrickx, L; Van der Auwera, G; Nkengasong, J; Beirnaert, E; Vereecken, K; Coppens, S; Willems, B; Fransen, K; Peeters, M; Ndumbe, P; Delaporte, E; van der Groen, C
      Interpatient genetic variability of HIV-1 group O

      AIDS
    65. Mulligan, MJ; Weber, J
      Human trials of HIV-1 vaccines

      AIDS
    66. Basak, A; Cooper, S; Roberge, AG; Banik, UK; Chretien, M; Seidah, NG
      Inhibition of proprotein convertases-1, -7 and furin by diterpines of Andrographis paniculata and their succinoyl esters

      BIOCHEMICAL JOURNAL
    67. Gorse, GJ; Patel, GB; Mandava, MD; Belshe, RB
      Vaccine-induced cytotoxic T lymphocytes against human immunodeficiency virus type 1 using two complementary in vitro stimulation strategies

      VACCINE
    68. Ibuki, K; Ido, E; Funahashi, S; Miura, T; Hayami, M; Shida, H
      Protective effects against simian immunodeficiency virus agm (SIVagm) infection in cynomolgus monkeys immunized with a recombinant vaccinia virus expressing the SIVagm envelope gene

      VACCINE
    69. Muhlbacher, M; Spruth, M; Siegel, F; Zangerle, R; Dierich, MP
      Longitudinal study of antibody reactivity against HIV-1 envelope and a peptide representing a conserved site on gp41 in HIV-1-infected patients

      IMMUNOBIOLOGY
    70. Moulard, M; Hallenberger, S; Garten, W; Klenk, HD
      Processing and routage of HIV glycoproteins by furin to the cell surface

      VIRUS RESEARCH
    71. Taverna, M; Tran, NT; Valentin, C; Level, O; Merry, T; Kolbe, HVJ; Ferrier, D
      A multi-mode chromatographic method for the comparison of the N-glycosylation of a recombinant HIV envelope glycoprotein (gp160s-MN/LAI) purified by two different processes

      JOURNAL OF BIOTECHNOLOGY
    72. Gemma, C; Opp, MR
      Human immunodeficiency virus glycoproteins 160 and 41 alter sleep and brain temperature of rats

      JOURNAL OF NEUROIMMUNOLOGY
    73. Haigwood, NL; Pierce, CC; Robertson, MN; Watson, AJ; Montefiori, DC; Rabin, M; Lynch, JB; Kuller, L; Thompson, J; Morton, WR; Benveniste, RE; Hu, SL; Greenberg, P; Mossman, SP
      Protection from pathogenic SIV challenge using multigenic DNA vaccines

      IMMUNOLOGY LETTERS
    74. Wright, PF; Lambert, JS; Gorse, GJ; Hsieh, RH; McElrath, MJ; Weinhold, K; Wara, DW; Anderson, EL; Keefer, MC; Jackson, S; Wagner, LJ; Francis, DP; Fast, PE; McNamara, J
      Immunization with envelope MN rgp120 vaccine in human immunodeficiency virus-infected pregnant women

      JOURNAL OF INFECTIOUS DISEASES
    75. Sei, S; Sandelli, SL; Theofan, G; Ratto-Kim, S; Kumagai, M; Loomis-Price, LD; Cox, JH; Jarosinski, P; Walsek, CM; Brouwers, P; Venzon, DJ; Xu, J; Pizzo, PA; Moss, RB; Robb, ML; Wood, LV
      Preliminary evaluation of human immunodeficiency virus type 1 (HIV-1) immunogen in children with HIV-1 infection

      JOURNAL OF INFECTIOUS DISEASES
    76. Evans, TG; Keefer, MC; Weinhold, KJ; Wolff, M; Montefiori, D; Gorse, GJ; Graham, BS; McElrath, MJ; Clements-Mann, ML; Mulligan, MJ; Fast, P; Walker, MC; Excler, JL; Duliege, AM; Tartaglia, J
      A canarypox vaccine expressing multiple human immunodeficiency virus type 1 genes given alone or with Rgp120 elicits broad and durable CD8(+) cytotoxic T lymphocyte responses in seronegative volunteers

      JOURNAL OF INFECTIOUS DISEASES
    77. Sitz, KV; Ratto-Kim, S; Hodgkins, AS; Robb, ML; Birx, DL
      Proliferative responses to human immunodeficiency virus type 1 (HTV-1) gp120 peptides in HIV-1-infected individuals immunized with HIV-1 rgp120 or rgp160 compared with nonimmunized and uninfected controls

      JOURNAL OF INFECTIOUS DISEASES
    78. Almond, N; Jenkins, A; Jones, S; Arnold, C; Silvera, P; Kent, K; Mills, KHG; Stott, EJ
      The appearance of escape variants in vivo does not account for the failureof recombinant envelope vaccines to protect against simian immunodeficiency virus

      JOURNAL OF GENERAL VIROLOGY
    79. Zhong, M; Munzer, JS; Basak, A; Benjannet, S; Mowla, SJ; Decroly, E; Chretien, M; Seidah, NG
      The prosegments of furin and PC7 as potent inhibitors of proprotein convertases - In vitro and ex vivo assessment of their efficacy and selectivity

      JOURNAL OF BIOLOGICAL CHEMISTRY
    80. Wouters, S; Decroly, E; Vandenbranden, M; Shober, D; Fuchs, R; Morel, V; Leruth, M; Seidah, NG; Courtoy, PJ; Ruysschaert, JM
      Occurrence of an HIV-1 gp160 endoproteolytic activity in low-density vesicles and evidence for a distinct density distribution from endogenously expressed furin and PC7/LPC convertases

      FEBS LETTERS
    81. Dellis, O; Bouteau, F; Guenounou, M; Rona, JP
      HIV-1 gp160 decreases the K+ voltage-gated current from Jurkat E6.1 T cells by up-phosphorylation

      FEBS LETTERS
    82. Okumura, Y; Yano, M; Murakami, M; Mori, S; Towatari, T; Kido, H
      The extracellular processing of HIV-1 envelope glycoprotein gp160 by humanplasmin

      FEBS LETTERS
    83. Courageot, J; Fenouillet, E; Bastiani, P; Miquelis, R
      Intracellular degradation of the HIV-1 envelope glycoprotein - Evidence for, and some characteristics of, an endoplasmic reticulum degradation pathway

      EUROPEAN JOURNAL OF BIOCHEMISTRY
    84. GENSBERG K; JAN S; MATTHEWS GM
      SUBTILISIN-RELATED SERINE PROTEASES IN THE MAMMALIAN CONSTITUTIVE SECRETORY PATHWAY

      SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
    85. LIU WF; GAO D; WANG ZN
      EXPRESSION OF THE EXTRACELLULAR DOMAIN OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ENVELOPE PROTEIN AND ITS FUSION WITH BETA-GALACTOSIDASE IN SACCHAROMYCES-CEREVISIAE

      Clinical and diagnostic laboratory immunology
    86. TSOUKAS CM; RABOUD J; BERNARD NF; MONTANER JSG; GILL MJ; RACHLIS A; FONG IW; SCHLECH W; DJURDJEV O; FREEDMAN J; THOMAS R; LAFRENIERE R; WAINBERG MA; CASSOL S; OSHAUGHNESSY M; TODD J; VOLVOVITZ F; SMITH GE
      ACTIVE IMMUNIZATION OF PATIENTS WITH HIV-INFECTION - A STUDY OF THE EFFECT OF VAXSYN, A RECOMBINANT HIV ENVELOPE SUBUNIT VACCINE, ON PROGRESSION OF IMMUNODEFICIENCY

      AIDS research and human retroviruses
    87. BRUHL P; KERSCHBAUM A; EIBL MM; MANNHALTER JW
      AN EXPERIMENTAL PRIME-BOOST REGIMEN LEADING TO HIV TYPE 1-SPECIFIC MUCOSAL AND SYSTEMIC IMMUNITY IN BALB C MICE/

      AIDS research and human retroviruses
    88. BINLEY JM; WYATT R; DESJARDINS E; KWONG PD; HENDRICKSON W; MOORE JP; SODROSKI J
      ANALYSIS OF THE INTERACTION OF ANTIBODIES WITH A CONSERVED, ENZYMATICALLY DEGLYCOSYLATED CORE OF THE HIV TYPE-1 ENVELOPE GLYCOPROTEIN-120

      AIDS research and human retroviruses
    89. COEFFIER E; GIRARD M; BARRESINOUSSI F; MEIGNIER B; MUCHMORE E; FULTZ PN; LECLERC C
      FINE SPECIFICITY OF ANTI-V3 ANTIBODIES INDUCED IN CHIMPANZEES BY HIV CANDIDATE VACCINES

      AIDS research and human retroviruses
    90. BERKOWER I; BRIDGEWATER J
      GENETIC-CONTROL OF THE IMMUNE-RESPONSE TO HIV TYPE-1 ENVELOPE GLYCOPROTEIN-120 IN MICE - EFFECTS OF MHC AND TRANSGENIC HUMAN CD4

      AIDS research and human retroviruses
    91. VALENTINE FT; PAOLINO A; SAITO A; HOLZMAN RS
      LYMPHOCYTE-PROLIFERATIVE RESPONSES TO HIV ANTIGENS AS A POTENTIAL MEASURE OF IMMUNOLOGICAL RECONSTITUTION IN HIV DISEASE

      AIDS research and human retroviruses
    92. Beyrer, C; Vancott, TC; Peng, NK; Artenstein, A; Duriasamy, G; Nagaratnam, M; Saw, TL; Hegerich, PA; Loomis-Price, LD; Hallberg, PL; Ettore, CA; Nelson, KE
      HIV type 1 subtypes in Malaysia, determined with serologic assays: 1992-1996

      AIDS RESEARCH AND HUMAN RETROVIRUSES
    93. OWENS DK; EDWARDS DM; SHACHTER RD
      POPULATION EFFECTS OF PREVENTIVE AND THERAPEUTIC HIV VACCINES IN EARLY-STAGE AND LATE-STAGE EPIDEMICS

      AIDS
    94. PONTESILLI O; GUERRA EC; AMMASSARI A; TOMINO C; CARLESIMO M; ANTINORI A; TAMBURRINI E; PROZZO A; SEEBER AC; VELLA S; ORTONA L; AIUTI F
      PHASE-II CONTROLLED TRIAL OF POSTEXPOSURE IMMUNIZATION WITH RECOMBINANT GP160 VERSUS ANTIRETROVIRAL THERAPY IN ASYMPTOMATIC HIV-1-INFECTED ADULTS

      AIDS
    95. LEANDERSSON AC; BRATT G; HINKULA J; GILLJAM G; COCHAUX P; SAMSON M; SANDSTROM E; WAHREN B
      INDUCTION OF SPECIFIC T-CELL RESPONSES IN HIV-INFECTION

      AIDS
    96. KELLEHER AD; ROGGENSACK M; JARAMILLO AB; SMITH DE; WALKER A; GOW I; MCMURCHIE M; HARRIS J; PATOU G; COOPER DA
      SAFETY AND IMMUNOGENICITY OF A CANDIDATE THERAPEUTIC VACCINE, P24 VIRUS-LIKE PARTICLE, COMBINED WITH ZIDOVUDINE, IN ASYMPTOMATIC SUBJECTS

      AIDS
    97. BARTLETT JA; WASSERMAN SS; HICKS CB; DODGE RT; WEINHOLD KJ; TACKET CO; KETTER N; WITTEK AE; PALKER TJ; HAYNES BF
      SAFETY AND IMMUNOGENICITY OF AN HLA-BASED HIV ENVELOPE POLYVALENT SYNTHETIC PEPTIDE IMMUNOGEN

      AIDS
    98. Belshe, RB; Gorse, GJ; Mulligan, MJ; Evans, TG; Keefer, MC; Excler, JL; Duliege, AM; Tartaglia, J; Cox, WI; McNamara, J; Hwang, KL; Bradney, A; Montefiori, D; Weinhold, KJ
      Induction of immune responses to HIV-1 by canarypox virus (ALVAC) HIV-1 and gp120 SF-2 recombinant vaccines in uninfected volunteers

      AIDS
    99. ROSS SA; KELLER SR; LIENHARD GE
      INCREASED INTRACELLULAR SEQUESTRATION OF THE INSULIN-REGULATED AMINOPEPTIDASE UPON DIFFERENTIATION OF 3T3-L1 CELLS

      Biochemical journal
    100. PIERDOMINICI M; MOLLICONE B; RICCI G; OLIVA A; DOFFIZI G; GIOVANNETTI A; AIUTI F; PANDOLFI F
      APOPTOSIS IN ASYMPTOMATIC HIV-1 SEROPOSITIVES IMMUNIZED WITH HIV-1 ENV GLYCOPROTEIN (GP160) - EFFECTS OF ADMINISTRATION OF ZIDOVUDINE IN-VIVO AND INTERLEUKIN-2 IN-VITRO

      Vaccine


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 26/01/21 alle ore 14:06:32